FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer ...Middle East

News by : (Medscape) -
Adding pembrolizumab to chemotherapy had significant benefits in patients with locally advanced unresectable or metastatic, HER2-negative gastric or gastroesophageal junction adenocarcinoma. Medscape Medical News

Hence then, the article about fda oks first line pembro with chemo for gastric gej cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار